0001672679-17-000001.txt : 20170711 0001672679-17-000001.hdr.sgml : 20170711 20170710212751 ACCESSION NUMBER: 0001672679-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170711 DATE AS OF CHANGE: 20170710 EFFECTIVENESS DATE: 20170711 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ascus Bioscience, Inc. CENTRAL INDEX KEY: 0001672679 IRS NUMBER: 473597285 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-290360 FILM NUMBER: 17958965 BUSINESS ADDRESS: STREET 1: 1396 POINSETTIA AVENUE CITY: VISTA STATE: CA ZIP: 92081 BUSINESS PHONE: 877-696-8945 MAIL ADDRESS: STREET 1: 1396 POINSETTIA AVENUE CITY: VISTA STATE: CA ZIP: 92081 D 1 primary_doc.xml X0707 D LIVE 0001672679 Ascus Bioscience, Inc. 6450 Lusk Blvd. E109/209 San Diego CA CALIFORNIA 92121 877-696-8945 DELAWARE Newco Fungi, Inc. None Corporation true 2015 Mallory Embree 6450 Lusk Blvd. E109/209 San Diego CA CALIFORNIA 92121 Executive Officer Director Peter Innes 6450 Lusk Blvd. E109/209 San Diego CA CALIFORNIA 92121 Director Jim Kim 6450 Lusk Blvd. E109/209 San Diego CA CALIFORNIA 92121 Director Michael Seely 6450 Lusk Blvd. E109/209 San Diego CA CALIFORNIA 92121 Executive Officer Director Thad Simons 6450 Lusk Blvd. E109/209 San Diego CA CALIFORNIA 92121 Director Erik Torgerson 6450 Lusk Blvd. E109/209 San Diego CA CALIFORNIA 92121 Director Other Health Care Decline to Disclose 06b false 2017-06-27 false true true false 0 7000000 5000000 2000000 Consists of Convertible Promissory Notes convertible into shares of Preferred Stock of the Issuer. false 9 0 0 0 false Ascus Bioscience, Inc. Michael Seely Michael Seely President and CEO 2017-07-06